Stugeron

Stugeron

cinnarizine

Manufacturer:

Janssen-Cilag

Distributor:

DKSH
Concise Prescribing Info
Contents
Cinnarizine HCl
Indications/Uses
Maintenance therapy for symptoms of labyrinthine disorders eg, vertigo, dizziness, tinnitus, nystagmus, nausea, vomiting; cerebrovascular origin eg, dizziness, tinnitus, vascular headache, unsociability & irritability disorders, loss of memory, lack of concentration; peripheral circulatory disorders eg, Raynaud's phenomenon, acrocyanosis, intermittent claudication, trophic disturbances, trophic & varicose ulcers, paraesthesia, nocturnal cramps & cold extremities. Prophylaxis of motion sickness, migraine.
Dosage/Direction for Use
Administration
Should be taken with food.
Contraindications
Special Precautions
Adverse Reactions
Somnolence & GI disturbances. Aggravation or appearance of extrapyramidal symptoms (prolonged use in elderly).
Drug Interactions
Alcohol/CNS Depressant/TCAs: Concurrent use may potentiate the sedative effects of these medications or of Stugeron.
MIMS Class
Antivertigo Drugs / Peripheral Vasodilators & Cerebral Activators
ATC Classification
N07CA02 - cinnarizine ; Belongs to the class of antivertigo preparations.
Presentation/Packing
Form
Stugeron 25 mg tab
Packing/Price
100 × 10's;25 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in